.Only 5 months after safeguarding a $100 million IPO, Vast Biography is currently giving up some wor...
.The first stages of oncology R&D may not be except intriguing brand new modalities, and also Hal...
.Psychopharmacology has actually drawn three short articles regarding midstage clinical trial inform...
.Avidity Biosciences amazed entrepreneurs along with phase 1/2 data in Duchenne muscular dystrophy (...
.Actinogen Medical's cortisol blocker has missed the main endpoint of a phase 2 research in anxiety,...
.Antibody-drug conjugates (ADCs) have been at the center of several a billion-dollar biobuck licensi...
.Resource supervisor TPG, which has assisted biotechs like Sionna Therapies and Santa Clam Ana Bio, ...
.Merck & Co.'s TIGIT plan has actually suffered yet another misfortune. Months after shuttering a...
.After a year described through pipeline hairstyles, the departure of its own chief executive office...
.Cullinan Therapy was blown away enough with Port BioMed's bispecific immune activator that it turne...